Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) Asset Writedowns and Impairment (2022 - 2024)

Updated

Oncotelic Therapeutics (OTLC) recorded Asset Writedowns and Impairment of $3.2 million in FY2024, down 47.5% from $6.1 million in FY2023.

Analysis

Oncotelic Therapeutics (OTLC) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends

  • Per Business Quant data, OTLC's Asset Writedowns and Impairment was $6.1 million in FY2023 (+48.4%) and $4.11 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 Oncotelic Therapeutics 8.28 Mn 7.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 3.20 Mn
Jun 30, 2023 6.10 Mn
Dec 31, 2022 4.11 Mn
API Access

Oncotelic Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=OTLC&period=max&api_key=YOUR_API_KEY